Differential regulation of angiotensin II receptors during renal injury and compensatory hypertrophy in the rat.
1. The renin-angiotensin system may be involved in the compensatory adaptations occurring after the reduction of renal mass and during the consecutive changes leading to chronic renal failure. We therefore investigated the regulation of angiotensin II receptors in two models of renal hypertrophy in the rat: hypertrophy following uninephrectomy (UNx) or subtotal nephrectomy (STNx). The level of angiotensin type 1 (AT1A-R and AT1B-R) and type 2 (AT2-R) receptor mRNA was quantified by competitive reverse transcription-polymerase chain reaction (RT-PCR) in specific renal zones and the intrarenal distribution of angiotensin II receptors was analysed by immunohistochemistry. 2. In the UNx rats, AT1-R mRNA expression was not modified in the cortex or in the inner stripe of the outer medulla of the residual kidney at any time after the surgery (1, 4 and 12 weeks). In contrast, AT1-R mRNA expression was significantly reduced in these zones in STNx rats (-33% and -40%, respectively). This downregulation was organ-specific, as AT1-R mRNA levels were not modified in the liver. The proportions of AT1-R subtype (AT1A and AT1B) mRNA were unchanged by UNx or STNx. Very low levels of AT2-R mRNA were found in the cortex of all groups. Immunostaining revealed a similar localization of AT1-R in mesangial cells, proximal tubule, basolateral membrane of thick ascending limb, in both models of hypertrophy. AT1-R labelling was also detected in the apical membrane of intercalated cells of cortical collecting ducts. 3. This differential mRNA expression of angiotensin II receptors during compensatory hypertrophy and renal injury suggests that the development of renal hypertrophy is independent of AT1-R and AT2-R gene expression levels.
Joly
Emma
E
Laboratory of Physiology and Pharmacology, Faculty of Medicine and Pharmacy, University of Mons-Hainaut, Mons, Belgium.
Nonclercq
Denis
D
Caron
Nathalie
N
Mertens
Jeannine
J
Flamion
Bruno
B
Toubeau
Gerard
G
Kramp
Ronald
R
Bouby
Nadine
N
D000818:Animals; D001835:Body Weight; D003401:Creatine / Q000097:blood / Q000652:urine; D015536:Down-Regulation / Q000235:genetics*; D004435:Eating; D006984:Hypertrophy / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D007150:Immunohistochemistry; D007668:Kidney / Q000293:injuries* / Q000378:metabolism / Q000473:pathology; D007672:Kidney Cortex / Q000737:chemistry / Q000378:metabolism / Q000473:pathology; D007679:Kidney Medulla / Q000737:chemistry / Q000378:metabolism / Q000473:pathology; D008099:Liver / Q000737:chemistry / Q000378:metabolism; D008297:Male; D009392:Nephrectomy; D009929:Organ Size; D051381:Rats; D017208:Rats, Wistar; D044140:Receptor, Angiotensin, Type 1 / Q000032:analysis / Q000235:genetics; D044139:Receptor, Angiotensin, Type 2 / Q000032:analysis / Q000235:genetics; D011945:Receptors, Angiotensin / Q000032:analysis / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014556:Urine / Q000737:chemistry
D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D011945:Receptors, Angiotensin; D003401:Creatine